Report from the Antimicrobial Progress Resistance in the area of Antimicrobial Resistance - Veterinary Medicines meeting, organised by the EMA and the HMA (veterinary), 15-16 September 2011.
This was a well attended meeting with relevant stakeholders represented. The presentations focused on the progress made in relation to veterinary medicines and antimicrobial resistance in the previous 18 months, current activities and plans for the future. The meeting discussed and agreed upon areas for prioritisation and greater collaboration, to ensure that existing antimicrobials remain effective, that antimicrobial resistance development is slowed and that animals can be treated with appropriate antimicrobials to ensure their health and safety, so contributing to the “One Health” agenda.
Common themes included:
- the need to examine the impact of existing initiatives, when deciding on future measures
- any measures should be science based and proportional to the risk
- the need for data to be directly comparable (surveillance and use) and a common definition for “resistance”
- the importance of clear, fact based communications
- antimicrobial resistance does not recognise political frontiers, any EU activity on antimicrobial resistance (AMR) should take place in a global context
- the need to differentiate between existing antimicrobials and new antimicrobials when authorising antimicrobial products
- the desire that the European Commission provides support, including funding, on the animal medicines side, as they have done for human medicines on key areas like training of veterinarians and farmers and campaigns to promote responsible use
See the attachment below for the full report.